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ABSTRACT 
The process of transforming the information stored in the DNA of genes into functional 
RNA molecules and proteins via transcription and translation is the most fundamental 
process of all known life. Even though these processes involve large macromolecules 
and dynamics on long time scales they all ultimately rely on atomic level interactions 
between nucleic acids or amino acids. Only a few experimental techniques are available 
that can study the large systems involved in atomic detail. Computer simulations, 
modeling biological macromolecules, are therefore an important tool in investigating 
fundamental biological processes. In this thesis, Molecular Dynamics (MD) simulations 
have been used to study the translation of mRNA by tRNA and the function of the 
regulatory riboswitches. The thesis also covers the improvement of methodology by the 
development of a new representation of the important Mg2+ ions and an improvement 
of the understanding of the connection between MD and experimental NMR data. 
 
In Paper I, the effect of post transcriptional modifications of the tRNA anti codon on 
the decoding of mRNA in the ribosome is studied. All atom MD simulations have been 
performed of the ribosomal A site with and without modifications present, including 
extensive free energy calculations. The results show two mechanism by which the 
decoding is affected: The further reach provided by the modifications allows an 
alternative outer conformation to be formed for the non cognate base pairs, and the 
modifications results in increased “catalytic” contacts between tRNA, mRNA and the 
ribosome. 
 
In Paper II, the folding mechanism of the add A riboswitch is studied under different 
ionic conditions and with and without the ligand bound. In addition to standard 
simulations, we simulated the unfolding by umbrella sampling of distance between the 
L2 and L3 loops. In the results, no significant effect of Mg2+ or Na+ ion environments 
or ligand presence can be seen. But a consistent mechanism with the P3 stem being 
more flexible than P2 is observed. More data might however be needed to draw general 
conclusions.  
 
In Paper III, the parameters describe Mg2+ ions in MD simulations are improved by 
optimizing to kinetic data of the H2O exchange. Data from NMR relaxation 
experiments was used as optimization goal. The newly developed parameters do not 
only display better kinetic properties, but also better agreement with experimental 
structural data. 
 
In Paper IV, the dynamical data, obtained from NMR relaxation experiment of a 
protein is related to dynamics seen in an MD simulation. The analysis provides 
important information for the interpretation of experimental data and the development 
of simulation methods. The results show, among other things, that significant parts of 
the entropy are not seen by NMR due to a limited time window and inability to account 
for correlation of motions. 
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1 INTRODUCTION 
 
 
“Somewhere, something incredible is waiting to be known.” 
- Carl Sagan (1934-1996), American scientist. 
 
 
 
 
 
 
 
 
 
 
 
Most tasks in a living cell are performed by RNA and proteins. Since the function of 
these molecules is closely related to their structure, the knowledge of their shape and 
dynamical behavior is essential to the understanding of biology. While some RNA and 
proteins function by themselves, many form large macromolecular complexes resulting 
in an incredible large diversity of shapes and sizes of these assemblies. Similar to 
individual RNA molecules and proteins, the complexes are not static in their functional 
state. Instead, they undergo functionally important, conformational changes, often 
triggered by ligand binding, in order to perform their specific biological activity. 
Examples of systems with a close connection between structure and function are the 
RNA-protein complex of the ribosome and the regulatory RNA-riboswitches. The 
science in which structure, dynamics and function is studied is called structural biology 
and it is the main theme of this thesis 
 
X-ray crystallography and Nuclear Magnetic Resonance (NMR) are the two most 
important experimental methods used to determine the three-dimensional (3D) structure 
of proteins at atomic resolution. X-ray crystallography has been an extremely useful 
tool for determining the structure of complex macromolecules. But to form crystals, the 
system needs to be in a single conformational state and X-ray crystallography 
consequently only provides a static picture, making information on dynamics or the 
structure of flexible regions hard to capture. The other method, NMR, has the 
advantage of studying molecules in solution and of being able to capture the dynamics, 
thus allowing the system to be in all its functional states. However, this technique is 
restricted to studying relatively small systems with high solubility in water. 
 
Computer simulations can overcome many of the limitations faced by the experimental 
techniques and have become a very important tool to compliment experiments in 
structural biology. Molecular Dynamics (MD) simulations provide a detailed view of 
the structure and dynamics of biomolecules on an atomic level. While limited in size 
and time of the studied systems, the exponential growth in computer power constantly 
expands the size of systems and length of processes that are achievable to simulate. 
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The first part of this thesis introduces the biological systems and processes studied in 
the four papers representing the original work of this thesis. The process in which the 
information in DNA is transformed into functional RNA and proteins is briefly 
introduced and the riboswitch and ribosome is described in more detail. The second 
part of the thesis discusses the methods used during my work. The basic equations and 
algorithms behind an MD simulation are presented together with some important 
choices that have to be made before starting a simulation. The main limitations of the 
methods and the connection to experimental techniques are also covered briefly. In the 
last part, the main results are summarized followed by the complete papers and 
manuscripts. 
   3 
2 BIOLOGICAL CONTEXT 
 
 
“However many ways there may be of being alive, it is certain that there are vastly 
more ways of being dead.” 
- Richard Dawkins (1941-), English biologist. 
 
 
 
 
 
 
 
 
 
 
 
Until the structure of DNA was discovered in 1953,[1-3] the way cells store all genetic 
information, needed to make up all living organisms, in the four letter code of DNA 
was unknown. The progress in knowledge has since then been astounding. After fifty 
years the complete genome for many organisms, including humans, has been 
sequenced. Although immensely more complex than anything humanity has ever 
assembled, all data needed create life forms such as humans can be fit on a single DVD 
disc. While this does not make biology easy to comprehend or study, it does set a clear 
limit on the amount of information needed to create life and it comforts us with that 
biology is at least not infinitely complex. 
 
2.1 THE CENTRAL DOGMA 
To create life from the genetic information stored in DNA, a polymer of four 
nucleotides. DNA is transcribed into RNA, a polymer similar to DNA but with an 
added hydroxyl group on the sugar and the uracil nucleotide instead of thymine. The 
RNA is in turn translated into amino acids that form functional proteins. Proteins are 
the main building block of living organisms and constitute most structural and 
functional parts of cells. This chain of events is central to all known life and has been 
named the central dogma of molecular biology (Figure 1). 
 
 
Figure 1. The Central dogma of molecular biology. Genetic information stored in DNA is transcribed 
into RNA by RNA Polymerase. The RNA is then translated into proteins by the ribosome. 
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During the first phase, transcription, a complimentary RNA chain is produced from the 
DNA template. The transcription process is carried out with the help of enzymes called 
RNA polymerase. Bacteria contain a single type of RNA polymerase and the RNA 
molecule is produced in a relatively straight forward process. It is initiated when RNA 
polymerase reads a promoter region of DNA, RNA polymerase then synthesizes the 
RNA during the chain elongation stage, terminates the transcription when reaching a 
terminator region and finally releases both the DNA template and the completed RNA 
molecule. In eucaryotic cells, the process of transcription is much more complex with 
three RNA polymerases, polymerase I, II, and III and it involves post transcriptional 
modification of mRNA (splicing) before leaving the nucleus. 
 
Protein coding mRNA is not the only RNA product of DNA transcription. The product 
can also be RNA that folds into functional (parts of) molecules needed for the 
upcoming protein synthesis such as the ribosome (rRNA), transfer-RNA (tRNA) and 
the regulatory riboswitches present in procaryotes. These molecules have functions 
similar to those of proteins and are believed to be relics from a time before the 
evolution of amino-acids and proteins, the so called RNA-world. 
 
In the translation process, the protein coding mRNA is picked up by the ribosome in 
the cytoplasm where it is translated into proteins via the genetic code (Figure 4). The 
amino acids used in the protein synthesis are first attached to a tRNA molecule, which 
then waits for its corresponding mRNA code to show up in the ribosome. When a 
match occurs, the tRNA binds to the ribosome and releases its amino acid. In this way, 
the entire sequence of nucleotides in the mRNA read according to the genetic code 
while an amino acids is transferred from the tRNA to the nascent peptide chain for each 
accepted codon. The protein then folds into its functional form on the way out from the 
ribosome. 
 
The biological processes studied in this thesis are the decoding of mRNA by the tRNA 
in the ribosome (Paper I) and the folding of the functional form of a riboswitch (Paper 
II). The structure and function of these two biological systems will therefore be 
described in more detail in the following pages. The studied systems both stem from 
bacteria and the focus of the discussion will be on prokaryotic systems and 
mechanisms. There are some key differences of these two systems in eukaryotic and 
prokaryotic organisms making them important targets for antibiotic agents and their 
potential role in the fight against antibiotic resistance among bacteria will also be 
highlighted. 
 
2.2 RIBOSWITCHES 
While most gene regulation in eukaryotic organism is performed by proteins, genetic 
regulation by RNA is widespread in bacteria. One common form of riboregulation in 
bacteria is the use of RNA sequences encoded within mRNA that directly affect the 
expression of genes encoded in the full transcript (called cis-acting elements because 
they act on the same molecule they are coded in). These regulatory elements are known 
as riboswitches. They are defined as regions of mRNA that bind metabolites or metal 
ions as ligands and regulate mRNA expression by forming alternative structures that 
promotes or inhibits the translation or transcription of the associated gene in response to 
this ligand binding.[4, 5] To date, it has been discovered that a variety of ligands are 
sensed by riboswitches; including magnesium ions, nucleic acid precursors, enzyme 
cofactors, and amino acid residues. Riboswitches are most often located in the 5' 
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untranslated region (5’-UTR), a stretch of RNA that precedes the start of protein coding 
mRNA regions, of bacterial mRNA (Figure 2). 
 
 
Figure 2. Schematic representation of an mRNA transcript including a riboswitch. The riboswitch is 
situated upstream of the coding region of mRNA with its aptamer domain in red, expression platform in 
blue and the common switching sequence in green. AUG and UAA are start and stop codons 
respectively. 
 
2.2.1 Basic Structure and Function 
The function of riboswitches is closely tied to the ability of RNA to form a diversity of 
structures. Unlike DNA, RNA with its additional hydroxyl group on the sugar is able to 
form a wider range of structures than the double helix of DNA. For example, a single 
strand of RNA can fold back on itself to form a hairpin, which is composed of a helix 
capped by a loop. In large RNAs, secondary structural elements such as helices and 
hairpins pack together into a specific pattern, to form intricate tertiary interactions such 
as the so called kissing loop interactions and base triplets and tetrads. These processes 
depend on positive ions to counter act the close packing of the negative charge of the 
phosphate groups of the RNA backbone (see section 2.4 for more details). 
 
Riboswitches are composed of two domains: the aptamer domain and the expression 
platform.[6] The aptamer domain (red in Figure 2) acts as a receptor that recognizes 
and binds the ligand. The expression platform (blue in Figure 2) acts directly on gene 
expression through its ability to toggle between two different secondary structures in 
response to ligand binding in the aptamer domain. Common to both domains is the so 
called the switching sequence (green in Figure 2). It is its binding, to either the aptamer 
domain or the expression platform that ultimately decides the expression outcome of 
the mRNA. Specifically, if metabolite binding to the riboswitch stabilizes the 
interactions of the switching sequence to the aptamer domain, the expression platform 
undergoes a conformation change, affecting its expression. 
 
The actual regulation is different among riboswitches and can be performed at both the 
transcription and translation stage of gene expression.[7] Riboswitches can signal 
transcriptional repression with a switching sequence that directs formation of a 
transcriptional terminator, a short stem-loop structure that signals RNA polymerase to 
abort transcription. The other main type of regulation targets the translation. These 
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riboswitches regulate the translational initiation by utilizing a switching sequence that 
expose or hide a ribosomal binding site called the Shine-Dalgarno sequence. (see 
section 2.3.3.1 for more details). 
 
2.2.2 Purine Riboswitches 
Riboswitches are usually organized into families and classes according to two features: 
the type of ligand they bind, and their secondary structure.[8] A family of riboswitches 
is typically a group of RNAs related by the ligands they recognize. Within a family, 
there may be distinct classes of riboswitches, each class distinguished by a common 
sequence pattern that usually defines the ligand-binding pocket, as well as features 
required for folding the RNA into a three-dimensional shape. An exception to this 
classification scheme is the purine riboswitch family, to which the add A-riboswitch 
(studied in Paper II and used as a model system in Paper III), belongs. This group of 
RNA shares a common secondary structure but can recognize multiple distinct 
ligands.[9] 
 
The purine family includes riboswitches that bind to adenine, guanine, and 2'-
deoxyguanosine. Because its members recognize multiple ligands, this riboswitch 
family serves as an excellent model for understanding the mechanisms of ligand 
recognition. The global architecture of the RNA in a purine riboswitch is defined by the 
organization of the three conserved helices joined by a central junction region (Figure 
3). Two of the RNA helices (P2 and P3) are situated on top of the third (P1), forming a 
Y-shaped structure and the terminal loops of P2 and P3 are held together by tertiary 
kissing loop interactions including a base quadroplex.[10] 
 
 
Figure 3. Aptamer domain of the add A-riboswitch. (A) 2-D secondary structure including stem base 
pair hydrogen bonds and residue numbering. Bonds to the ligand are shown as full lines for Watson-Crick 
interactions and dashed lines for non Watson-Crick interactions. (B) 3-D structure colored according to 
labels in A from the X-ray structure by Serganov et al.[10]. 
 
   7 
2.2.2.1 Ligand Binding and Regulatory Mechanism 
The ligand-binding pocket of a purine riboswitch is situated in the three-way helical 
junction where P1, P2, and P3 meet. This region of the RNA is defined by a series of 
non-canonical base interactions, such as a base triplet between residues far apart in the 
RNA sequence (A21-U75•C50). At the center of the junction, a pyrimidine at position 
74 forms a Watson-Crick base pair with the ligand, which is bound further by other 
conserved residues. The identity of this pyrimidine residue (cytosine or uridine) is the 
basis for specificity between the guanine and adenine classes.[11] When the ligand is 
bound in its pocket, it is completely encapsulated by the riboswitch making it 
inaccessible to the aqueous environment, a feature common to many riboswitches.[6] 
 
This encapsulation of the purine ligand is accompanied by both local and global 
conformational changes. On the local level, the J3-1 strand of the junction, acts as a 
preformed docking station for the incoming purine ligand by making Purine74 
available for Watson-Crick pairing. Once the ligand is bound, nucleotides comprising 
J2/3 fold over the ligand and encapsulate it. The ligand binding (together with Mg2+ 
ions) is also closely associated to the overall folding of the entire riboswitch 
structure.[6, 12] In the add A-riboswitch specifically, the binding of the adenine ligand 
strongly promotes the kissing loop interactions between P2 and P3 and the base pairing 
of P1.[13] 
 
The coupling of ligand binding to a conformational change is central to the regulatory 
mechanism of purine riboswitches. As J2/3 covers the ligand, it also forms additional 
tertiary interactions with the switching sequence at 3’ end of the P1 stem (Figure 2, 
green). These additional ligand-induced interactions with the P1 helix stabilize its 
incorporation into the aptamer domain. At the same time, this prevents the P1 helix 
from being able to form alternative structures with the expression platform. In this way, 
the expression platform forms one of two “on and off structures” that interface with the 
expression machinery: either RNA polymerase or the ribosome. 
 
In the add A-riboswitch the ligand binding stabilizes the folded aptamer domain, which 
leaves the expression domain in the on structure able to interact with the Shine 
Delgarno sequence of the ribosome and initiate translation. If the ligand is not bound 
after the transcription of the riboswitch, the expression platform rapidly equilibrates 
into a lower-energy off structure, unable to bind to the ribosome and thus repressing 
gene expression. This is an example of positive feedback to the presence of ligand but 
riboswitches that provide negative feedback (by repressing gene expression when 
ligand is bound) are also known.[6] 
 
2.3 RIBOSOMAL TRANSLATION 
At the heart of translation of mRNA into the peptide chains of proteins lies the genetic 
code (Figure 4). This code is the link between the ribonucleotides of mRNA and the 
amino acid sequence of the final proteins. It is nearly completely universal with the 
same “dictionary” being used in close to all known organism across all domains, 
including viruses. It is written in a linear form consisting of 61 triplets of nucleotides 
called codons each specifying one amino acid. Among the codons are also the “start” 
and “stop” triplets that specify where the translation should be initiated and terminated. 
The code is unambiguous but degenerate, meaning that each triplet specifies only one 
single amino acid but that a given amino acid can be specified by more than one triplet 
codon. In fact, almost all amino acids are specified by two, three, four or even six 
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different codons. Only tryptophan and the methionine start codon are encoded by single 
codons (see color coding in Figure 4) 
 
 
Figure 4. The genetic code. The codons (three-base code words) are translated into the 20 amino acids 
denoted by in their three letter codes. The codons are colored according to their degeneracy, grey for 
unique, yellow for twofold, magenta for threefold, green for fourfold, and blue for six fold.  
 
When studying the degeneracy of the genetic code a pattern soon becomes apparent. 
Most often in a set of codons specifying the same amino acid, the first and second 
letters are the same with only the third one differing. When observing this Francis 
Crick formulated the Wobble hypothesis in 1966.[2] The hypothesis states that the third 
letter of the codon is read less accurately than the two first, allowing mismatches in the 
third so called wobble position. This relaxed base-pairing requirement allows the anti-
codon of single tRNA to pair with more than one codon of mRNA. This means that a U 
at the first position (the 5’-end) of the tRNA anticodon may pair with A or G at the 
third position (the 3’-end) of the mRNA codon and G may likewise pair with U or C at 
the wobble position. In addition to this near-cognate wobbling, later research has found 
that certain tRNAs are able to read, not only near cognate bases, but all four bases at the 
wobble position.[14] This ability requires post transcriptional modifications of the 
tRNA anti-codon and is described in more detail in section 2.3.1 below. When these 
wobble rules are applied a theoretical minimum of about 30 different tRNA species is 
necessary to account for the 61 triplets coding for an amino acid. The evolutionary 
reason for the wobble capability is considered to be an economy measure. Current 
estimates are that 30-40 tRNA species are present in bacteria and up to 50 are present in 
animal and plant cells. 
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2.3.1 tRNA  
The decoding process where the nucleotide sequence of mRNA is translated into the 
amino acid sequence of the protein is performed by tRNA molecules, carrying one 
amino acid each, on the ribosome. When a codon in the mRNA calls for a particular 
amino acid, the tRNA carrying that amino acid will recognize the specific codon and 
deliver its amino acid to the growing polypeptide chain. tRNAs consist of a single 
stranded RNA molecule, about 75 nucleotides long, folded into a L-shaped hairpin 
arrangement (Figure 5). The structure (first revealed over 35 years ago[15, 16]) 
contains four stems that are stabilized by Watson-Crick base pairing, three of which 
have loops (inset Figure 5). The middle hairpin (blue) harbors the anti-codon (grey), the 
nucleotide triplet that base-pair to the corresponding codon in mRNA. The other two 
hairpins (red and green) make up the L-shaped center of the tRNA molecule. The 
fourth stem (purple) is composed of the 3’- and 5’-ends of the chain and this unlooped 
stem is referred to as the acceptor or aminoacyl (aa) stem. All tRNAs have a conserved 
CCA sequence at their 3’-end that is not base-paired (yellow). The free 2’-hydroxyl or 
3’-hydroxyl of the terminal adenosine is covalently attached to the amino acid, forming 
an aa-tRNA. 
 
 
Figure 5. Structure of tRNAPHE from yeast. Inset shows 2-D secondary structure. Purple: acceptor 
stem, red: D-loop, blue: anticodon loop, orange: variable loop, green: TPsiC-loop, yellow: CCA-3' of the 
acceptor stem and grey: anticodon. X-ray structure from PDB: 1ehz.[17] Adapted from the Wikimedia 
Commons file: “TRNA-Phe yeast 1ehz.png”, http://commons.wikimedia.org/wiki/File:TRNA-
Phe_yeast_1ehz.png. 
 
tRNA molecules have one of the highest frequencies of post transcriptional base 
modifications of all known biomolecules. Base modifications are extra atomic groups 
that are attached to any of the standard nucleotides after the transcription from DNA to 
RNA. Although modification of nucleosides comes at a considerable genetic and 
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energetic cost (most modifications demand their own enzyme), more than 70 distinct 
modifications have been identified on the known tRNAs. The modifications can be 
situated in all domains of the tRNA and are conserved in many organisms.[18, 19] 
However, the most universally conserved modified bases are situated a close to the 
anticodon, especially in position 34 and the purine 37 on the 3’ side of the anticodon. 
The modifications in these places vary greatly in size, ranging from simple methyl 
groups to complex structures with multiple functional groups, but are all with little 
doubt involved in the recognition of the mRNA codon[20]. It is these modifications that 
let certain tRNA accept all four mRNA bases at the wobble position in the codon. The 
mechanism of this expanded decoding is studied in detail in Paper I in this thesis. 
 
2.3.2 The Ribosome - Structure 
The ribosome is the molecular machine responsible for all protein synthesis in the cell. 
It is a large particle, consisting of two subunits made up from a mixture of ribosomal 
RNA (rRNA) and proteins. The size of the two subunits as well as some of the steps in 
the translation process varies between eukaryotic and prokaryotic organisms. In this 
thesis only the bacterial ribosome has been studied and therefore only the prokaryotic 
ribosomal structure and mechanisms will be covered here. 
 
The structure in atomic resolution of the ribosome remained unknown for long but was 
solved during the last decade by Thomas A. Steitz,[21] Venkatraman 
Ramakrishnan[22] and Ada E. Yonath[23] and was awarded the Nobel Prize in 
chemistry 2009. In bacterial ribosomes the two subunits are called the 30S (small) and 
the 50S (large) subunit. These ribosomal subunits have irregular shape, but together 
they form a fairly globular complex with a cleft between them through which the 
mRNA and tRNA molecules binds and transits (Figure 6). The simplest bacterial and 
archeal ribosomes contain three rRNA chains, forming the core of the ribosomal 
subunits and comprising about 66 % of the total mass, and more than 50 proteins 
representing the remaining 33 %. The 30S subunit has one large rRNA molecule (16S 
RNA) while the 50S subunit has two rRNA molecules, one large (23S RNA) and one 
smaller (5S RNA). In both subunits it is the large rRNA molecule that provides the 
binding sites for the ribosomal proteins. Most of the ribosomal proteins are located at 
the solvent exposed surface of the subunits. 
 
There are three binding sites for tRNA molecules on the ribosome and all three are 
situated on the interface between the 30S and 50S subunit and are thus surrounded by 
both. The first binding site is the A (aminoacyl) site where the incoming aa-tRNA first 
binds and selection between cognate and non-cognate tRNA molecules takes place at 
the decoding center. If the tRNA is accepted it is transferred to the P (peptidyl) site 
where the carried amino acid is added to the nascent peptide chain at the peptidyl 
transfer center (PTC). tRNA molecules are able to concurrently contact the decoding 
site on the 30S subunit and the PTC on the 50S subunit because of their L-shaped 
structure where the anticodon is at one side and the aminoacyl tail is at the opposite 
side, about 75 Å apart. Finally the deacylated tRNA is moved to the E (exit) site before 
leaving the ribosome. The A site is located at the side of the L7/L12- stalk, the E site is 
at the L1-side of the ribosome and P site is situated between them at the center of the 
ribosome. 
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Figure 6. The prokaryotic 70S ribosome with three bound tRNAs and mRNA. The 50S subunit is 
colored pale blue and the 30S subunit is colored pale pink. Ribosome coordinates from he X-ray structure 
by Selmer et al..[22] 
 
The movements of the tRNA molecule through the ribosome hint at the dynamic nature 
of the ribosome which undergoes large scale conformational changes as part of its 
function.[24] In the 30S subunit, the large-scale dynamics mainly takes place around 
the decoding center, which undergoes a conformational change from an ”open” to a 
”closed” form after a cognate codon:anticodon interaction is registered.[25] In the 50S 
subunit, it is mainly the protuberances of the L1 and L11 stalk (situated on the opposite 
side of the ribosome from L1) that display large scale dynamics. The L1 stalk is 
involved in the release of the deacylated tRNA from the E site. The biological functions 
of L11 is not completely known but is thought to be associated with the hydrolysis of 
the energy bearer GTP by its hydrolization enzyme GTPase.[26] 
 
2.3.3 Ribosomal Translation – The Three Steps 
The translation process can be divided into three distinct steps: initiation; elongation 
and termination. The process is powered by the hydrolisation of GTP to GDP and is 
executed with the help of several cofactors, of which all will not be mentioned in the 
short description below. The translation process has been reviewed in more detail by 
Ramakrishnan[27] and Steitz[28]. 
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2.3.3.1 Initiation 
Protein synthesis is initiated when an mRNA molecule binds to the free 30S subunit 
(without the 50s unit). Correct initiation requires that the start codon (generally AUG) 
is positioned in the ribosomal P site. In bacteria, the 30S subunit identifies the start 
codon by forming interactions between its 16S RNA molecule and the so called Shine-
Dalgarno sequence located upstream of the AUG start codon in the mRNA chain.[29] 
After the correct placement of the start codon in the P site of the 30S subunit, the 
“start” tRNAMet bind to the P site with the help of initiation factors (IF). With the help 
of energy from GTP and other initiation factors the 50S ribosomal subunit binds to 30S 
subunit. After release of all IFs, the result is the 70S ribosome with tRNAMet in the P 
site that is ready for elongation.  
 
2.3.3.2 Elongation 
The elongation step of the translation can be divided into three separate sub-steps: 
 
1. Elongation starts with the binding of an aa-tRNA in complex with an elongation 
factor (EF-Tu) and GTP to the A site of the ribosome. Here the mRNA codon is 
matched with the tRNA anti-codon by the formation of three base pairs (see 
below for more details on the decoding process). If accepted, EF-Tu will 
hydrolyze its bound GTP and undergo a conformational change. The EFTu 
·GDP complex has a low affinity for the aa-tRNA and the ribosome resulting in 
its dissociation from the aa-tRNA. This will free the aminoacyl end of tRNA 
and allow it to move into the P site and reach the PTC on the 50S subunit, 
where the peptide is synthesized. 
2. The formation of the peptide bond between the amino acid brought by the 
tRNA and the nascent peptide chain takes place at the PTC with the help of 
peptidyl transferase, which is an enzymatic function of rRNA that catalyzes the 
formation of peptide bonds. 
3. The final step of elongation is the translocation of tRNA. The now deacylated 
tRNA leaves the P site and exits via the E site. Meanwhile, a new aa-tRNA that 
is accommodated in the A site moves into the P-site together with its 
corresponding mRNA codon, exposing the downstream codon at the A-site. 
This process is catalyzed by elongation factor G (EF-G). 
 
This three step process is repeated until a stop codon in the mRNA strand is reached at 
the A site. 
 
The decoding of mRNA and selection of the correct tRNA for participation in the 
addition of a new amino acid to the growing polypeptide chain is entirely based on the 
base pairing between the codon on mRNA and the anticodon on tRNA. However, the 
energy difference in base pairing of cognate tRNA, and that of near-cognate tRNA 
(generally consisting of only a single mismatch) is too small to account for the accuracy 
of selection, which has been found to have an error rate of 10−3 to 10−4.[30] 
 
How can this high accuracy achieved? It turns out that the ribosome has several ways 
of augmenting the differences between base pairs to increase the accuracy.[25] Firstly, 
the decoding site of the 30S subunits works much like an enzyme by recognizing and 
stabilizing the geometry of correct codon-anticodon base pairing and sterically 
discriminates against mismatches. This is achieved by the formation of hydrogen bonds 
between the ribosomal residues A1492, A1493 and G530 and the tRNA and mRNA 
when Watson-Crick base pairs between the anti-codon and codon are present (see 
Figure 2 in Paper I of this thesis for more details). Secondly, the ribosome asserts a 
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“kinetic proofreading” by splitting the selection step into an initial selection and a 
proofreading step. The two steps are separated by an irreversible reaction, such as the 
hydrolysis of GTP by EF-Tu preventing once discarded tRNA to be evaluated again. In 
this scheme, an incorrect tRNA has two chances to dissociate, once during initial 
selection and once after GTP hydrolysis and release of EF-Tu. Theoretically, this 
process results in a selectivity that is the product of the selectivity at each step. A third 
way of increasing (or decreasing) the selectivity is by the addition of modified bases 
discussed in section 2.3.1 and studied in Paper I. 
 
2.3.3.3 Termination 
Protein synthesis is terminated when one of the three stop codons UAA, UAG or UGA 
is exposed at the A site. Three release factors (RF) work in concert to terminate the 
translation process. Two of them recognize the stop codons and then hydrolyze the 
polypeptide chain from the last tRNA in the P site. The third release factor is a GTPase, 
and its function is to remove two other release factors from the ribosome.[31] After the 
termination step and release of the produced peptide chain, the ribosome is prepared for 
a new round of translation by the separation of the two subunits and dissociation of the 
mRNA and the deacylated tRNA. This process is promoted by the ribosome recycling 
factor together with EF-G. 
 
2.4 IONS AND RNA 
Each nucleic acid residue in DNA and RNA carries a -1 charge at the backbone 
phosphate group in aqueous solution and physiological conditions. In DNA, with its 
ordered double helical structure, the phosphate groups are kept far apart and the 
repulsion of the negative charges does not create problems for the effective folding to 
DNAs helical structure. RNA with its additional hydroxyl group, folds in much more 
intricate ways, often packing the negative phosphate groups close together in space. To 
overcome the electrostatic repulsion hindering the folding of RNA to its functional 
forms, it has been found that positive metal ions are integrated in the structure and 
dynamics of RNA.[32, 33] 
 
2.4.1 Types of Ions in RNA  
Of the ions found in the cell, Na+, K+, Mg2+ and Ca2+ are present at the highest 
concentration. While they all have been showed to be involved with RNA structure, the 
monovalent cations, sodium (Na+) and potassium (K+), and the divalent cations, 
magnesium (Mg2+) and calcium (Ca2+) influence the structure and folding of RNA 
more and less effectively. Mainly two factors determine the effectiveness of an ion to 
stabilize RNA structures: charge and size. The divalent Mg2+ has been found to have a 
large stabilizing effect on RNA structure even in the presence of a 100-fold excess of 
monovalent cations.[34, 35] The ionic size is relevant to ion-RNA interactions in two 
ways: aside from the obvious steric problem of fitting a large ion into an RNA binding 
site, the radius also determines the strength of the electrostatic field. The smaller the 
radius of an ion is, the greater the charge density and the stronger its interactions with 
water and RNA atoms. 
 
With these factors is mind, Mg2+ stands out as being the most relevant for RNA 
stability and folding.[36, 37] Mg2+ ions are characterized by a high charge density and 
strong electrostatic field due to the +2 charge and small radius (~0.65 Å). This gives the 
 14 
ion the ability to transfer a large amount of charge into sterically confined spaces and 
effectively mitigate the negative charge. The high charge density also results in 
extremely strong interactions with water molecules. Mg2+ forms a complex of six water 
molecules ([Mg(H2O)6]+2) packed in a octahedral arrangement and surrounded by a 
second solvation shell of twelve less strongly bound water molecules. In comparison; 
K+, the most common metal in physiological conditions, has with its 1.3 Å radius and 
+1 charge considerably weaker interactions, both with RNA and surrounding water 
molecules. Another reason for the more efficient stabilization of RNA by Mg2+ (and 
other divalent ions) is a smaller entropic cost for the association of ions to an RNA 
molecule. Due to their higher charge density, fewer ion have to by restricted to the 
surface of the RNA molecule resulting in a lower entropy cost.[38] 
 
2.4.2 Types of Ion Binding to RNA 
Metal ions can bind to RNA in two ways: directly by replacing 1-3 of the waters in the 
first solvation shell with RNA atoms (inner sphere contact) or indirectly with one of the 
first shell water molecules bridging between the ion and the RNA acceptor atom (outer 
sphere contact) (Figure 7). The type of binding has significant effects on the properties 
of the interaction, especially for Mg2+ which binds several orders of magnitudes 
stronger than Na+, K+ and Ca2+. While each direct interaction is stronger than an 
indirect, the view that the main stabilizing contribution comes from direct binding has 
received less support lately and it is now believed that indirect contacts are responsible 
for most of the stabilizing effect that Mg2+ ions have on RNA structures.[39, 40] The 
importance of indirect interactions to the overall stability of RNA can be attributed to 
their significantly greater number. The relative scarcity of direct interactions can in turn 
be explained by the high free energy cost associated with the partial dehydration of the 
[Mg(H2O)6]+2 complex[32] and RNA systems[41] that is required for direct binding. 
The cost of preparing the ion for direct binding is larger than the gain from the stronger 
interactions. 
 
 
Figure 7. Direct (a) and indirect (b) binding of an Mg2+ ion to an RNA phosphate group. 
Magnesium atoms are in grey, phosphor in orange, oxygen in red, carbon in green and hydrogen in white. 
 
2.4.3 Ions in Riboswitches and the Ribosome 
The ribosome, the largest natural RNA structure, unsurprisingly requires many cations 
to form its folded, functional form. High resolution X-ray structures of the ribosome 
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have revealed 60 directly bound Mg2+ ions and 88 monovalent ions in the 50S subunit 
alone[42] but many more of the “hard to detect”, indirectly bound ions are expected. 
Although the functional centers of the ribosome are densely packed with divalent metal 
ions, the ions have not been found to directly participate in the ribosomal function. The 
main function of the ribosomal ions is however believed to be to promote the folding 
and stability of the ribosome’s functional architecture.[33] 
 
Recent investigations have also elucidated the role of Mg2+ ions in the folding of 
riboswitches. It has been shown that a high Mg2+ concentration can compensate for the 
absence of a bound ligand and promote the structure formed with the correct ligand 
bound.[43, 44] Two studies of adenine riboswitches have also found that the presence 
of Mg2+ strongly stabilizes the folded state and that Mg2+ enhances the stability of the 
kissing loop structure and the binding pocket, which leads to an increased affinity for 
the adenine ligand.[31, 40] 
 
2.5 ANTIBIOTICS AND RNA 
With the surge in antibiotic resistance seen in clinics all over the world, the need for 
novel drug targets in bacteria becomes more and more acute. While RNA was believed 
to lack the chemical diversity of proteins and thus not be good targets for drugs, we 
now know that it has many attractive characteristics. Like proteins, RNA can fold into 
intricate 3-D structures with pockets and cavities that have the potential to bind ligands 
specifically. RNAs, such as the ribswitches, undergo extensive structural rearrangement 
upon associating with small molecules, and therefore exist in multiple distinct 
conformations that can be targeted. In addition, many cellular RNAs are subjected to 
extensive post-transcriptional modifications, which increases their chemical versatility 
further.[45] The characteristics together with key differences between prokaryotic and 
eukaryotic cells and RNA’s close connection with gene expression make RNA 
molecules enticing antibiotics targets. The majority of antibiotics in clinical use target 
the rRNA of the ribosome,[46] but novel and promising drug candidates targeting 
riboswitches are currently in development.[47] 
 
2.5.1 Antibiotics Targeting the Ribosome 
Antibiotics that target the ribosome almost exclusively bind to one of three functional 
sites: the decoding (A-site) on the 30S, the PTC (P- site) on the 50S, and the peptide 
exit tunnel on the 50S subunit.[48] Antibiotics that bind the A-site, such as 
aminoglycosides, interfere mainly with codon recognition. At the decoding center, the 
binding of these aminoglycosides induces a conformational change of ribosomal 
residues A1492, A1493 and G530 (see section 2.3.3.2) that mimics the structure 
corresponding to Watson-Crick base pairing between the codon and anti-codon. This 
results in the acceptance of non-cognate tRNAs and malfunctioning proteins. Drugs 
targeting the P site, like oxazolidinones, inhibit the actual protein synthesis by either 
hindering tRNA substrates from binding or disrupting peptide bond formation by 
binding to the PTC itself. Finally, antibiotics that target the peptide exit tunnel function 
by blocking the growth of the nascent amino acid chain at the peptide exit tunnel. This 
prevents the elongation process and results in incomplete proteins. 
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2.5.2 Antibiotics Targeting Riboswitches 
Riboswitches are attractive targets for new drugs for two additional reasons compared 
to other RNA. First, riboswitches evolved to recognize small molecules. Although 
numerous RNA domains have been experimentally targeted for drug discovery, small 
molecule binding to these RNAs is often circumstantial, not related to their 
physiological function.[49] Ligands targeting such RNAs can exhibit poor 
selectivity.[50] Second, almost all known riboswitches occur predominantly in bacteria, 
not eukaryotes. If eukaryotes do employ riboswitches, it is likely that these will be 
distinct from those of bacteria, minimizing cross-reactivity of bacterial riboswitch 
targets. 
 
Several antibiotic compounds (e.g. roseoflavin and pyrithiamine) with previously 
unknown mechanism have recently serendipitously been found to target 
riboswitches.[49] These molecules are highly similar to the cognate ligands of the FMN 
and TPP riboswitches respectively and inhibit gene expression by inducing the off state 
of the riboswitch. Active development of drugs targeting the guanine (Purine) 
riboswitch is currently also being performed.[51, 52] Guanine analogues differing in 
the C2 and C6 positions have been shown to bind and inhibit growth significantly, also 
in bacteria known for antibiotics resistance. Compound stability and bioavailability are 
however problems yet to be solved. 
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3 METHODOLOGY 
 
 
“It is unworthy of excellent men to lose hours like slaves in the labor of calculation, 
which could be relegated to anyone else if machines were used.” 
- Gottfried Wilhelm von Leibnitz (1646-1716), 
 German philosopher and mathematician. 
 
 
 
 
 
 
 
 
 
 
 
Molecular modeling is the science of studying molecular structure and function through 
structure building and computation. The structures usually consist of atomic 
coordinates of large biomolecules, metals and small, bound organic molecules obtained 
from experimental methods like X-ray crystallography or NMR-spectroscopy. The 
computational methods stretch from detailed ab initio and semi-empirical quantum 
mechanics, through empirical molecular dynamics and Monte Carlo simulations to the 
large scale, less detailed coarse-graining and homology modeling. 
 
The questions that can be addressed by computational approaches today are as complex 
as the biological systems themselves. Possible inquires range from understanding the 
equilibrium structure of a small biomolecule, the energetics of hydrogen-bond 
formation in proteins and nucleic acids, binding affinities of ligands/drugs to their 
target to the complex kinetics of macromolecular folding and functioning of 
supramolecular aggregates. Molecular modeling provides a way to systematically 
explore structural/dynamical/thermodynamic patterns, and test and develop hypotheses 
to help understand and make practical use of the structure, flexibility and function of 
biomolecules. 
 
Simulations of systems of the size of macromolecules like proteins and folded nucleic 
acid molecules are generally carried out with methods based on classical physics like 
Molecular Dynamics (MD) and Monte Carlo (MC). While structural configurations are 
generated randomly in MC simulations, MD simulation generates a trajectory of 
structures connected in time. The time scales studied with MD simulations typically 
range from picoseconds (10-12 s) to microseconds (10-6 s) but simulations on the 
millisecond (10-3 s) scale have been reported recently.[53] In this thesis only MD 
simulations have been used and they will be described in more detail below. 
 
3.1 MOLECULAR DYNAMICS SIMULATIONS 
Many software packages that perform MD simulations exists, but the for most widely 
spread include: CHARMM[35, 54], AMBER[55], GROMACS[56] and NAMD[57]. 
The work presented in this thesis has been carried out exclusively using the CHARMM 
package. While these packages are subjected to constant development, the proper and 
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effective usage of them is far from generally applicable, automated procedures and 
their application relies on user expertise as well as biological intuition. 
 
Many successful MD studies have been published since the first simulation of a protein 
was reported in 1977[58] thanks to the development of more effective algorithms and 
the explosive increase in computer power. Numerous applications have surfaced, 
including the refinement of low-resolution experimental structures[59], interpretation 
of various experimental data such as single-molecule force-extension curves[39] or 
NMR spin-relaxation in proteins[60-62] and improvement of structure-based function 
predictions, for example, by predicting calcium-binding sites[63]. MD simulations are 
also an important tool in calculating free energy differences and have been able to 
estimate the importance of quantum effects in lowering free-energy barriers of 
biomolecular reactions[64] and to propose free-energy pathways and associated 
mechanisms.[65, 66] MD simulations have also been an important tool in developing 
an understanding of enzyme binding-pockets[67, 68] and the interactions of drug 
compounds[69]. 
 
3.1.1 Force Fields 
At the core of a classical MD-simulation lies the force field, which is responsible for 
the description of the potential energy of a system of particles. The force field consists 
of two main components: the potential energy function and the parameters used in the 
function. The parameters are derived empirically to reproduce available experimental 
data or detailed quantum mechanics calculations on small model compounds. The 
successful parameterization of biological systems is heavily dependent on highly 
detailed experimental data on structure, dynamics and energetic. This have until 
recently limited the development of accurate force fields, especially for nucleic acids, 
for which less data is available compared to proteins. 
 
The potential energy function used in CHARMM consists of bonded energy terms 
(bonds, angles and torsions) to the non-bonded terms (van der Waals and electrostatic): 
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The three bonded terms represent the stretching of bonds, the bending of angles and the 
rotation of dihedrals. kb, kθ and kχ are the force constants for the bond length, bond 
angle and the dihedral angle respectively. The values of these variables in the current 
configuration are denoted b, θ and χ, while the values representing the potential energy 
minima are denoted with the subscript zero. The rotation of a dihedral is periodic with 
periodicity n and phase σ. In the non-bonded term i, j are all atom pair combinations 
within a cutoff distance, q is the charge of atoms i or j, 0ε  is the permittivity of vacuum 
and 1ε  is set to 1 for explicit solvents and ijr is distance between atom i and j. ijε  and 
min,ijR  are the combined atomic Lennard-Jones parameters, specifying the depth ( ijε ) 
and position ( min,ijR ) of energy minimum. ijε  is obtained by the geometric mean of the 
two atomic parameters, ij i jε ε ε= , found in the parameter set while, min,ijR , is 
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obtained by the arithmetic mean of the two atomic parameters, min, min,min, 2
i j
ij
R R
R
+= . 
To avoid an insurmountable number non-bonded pairs that should be evaluated at each 
dynamics step, a distance cutoff is introduced to limit pairs to surrounding atoms. 
While this cutoff provides a considerable decrease in computational cost, it also 
introduces a significant approximation by neglecting all non-bonded interactions 
outside the cutoff. Several methods that account for long-range electrostatics exist, but 
one of the most widely used is the particle mesh Ewald (PME) algorithm which provide 
an accurate but computational affordable representation of long-range electrostatics. 
[70, 71] 
 
A number of empirical force fields, used for the simulation of biomolecular systems, 
have evolved during the recent decades. The most widely used are currently 
CHARMM[54, 72], AMBER[57, 73], GROMOS[74] and OPLS[75]. The form of the 
potential energy function, used to describe specific interactions, is very similar between 
these force fields but there are differences in the actual values of the specific 
parameters and how they are implemented in the potential energy function. The largest 
differences lies in the parameters describing the non-bonded interactions, i.e. the partial 
charges used to represent the electrostatic interactions between molecules and the 
Lennard-Jones terms used to represent the van der Waals interactions between atoms. 
But it is also important to note that each parameter exists in a delicate context together 
with other parameters in each of the force fields. Modifying a parameter or inserting 
parameters from one force filed into another might cause severe and unexpected 
problems in other parts of the parameter sets. The quality of MD simulations is 
ultimately heavily dependent on the accuracy of the empirical force fields and an 
improvement of the Mg2+ ion parameters is presented in Paper III.  
 
3.1.2 Molecular Dynamics Calculations 
In an MD simulation the movements of the simulated atoms are described by Newton’s 
second law of motion, F ma= , where F is the force acting on the particle, m is its 
mass and a is its acceleration. Newton’s equation of motion can be applied if the 
positions and velocities are known or can be assumed and if all forces acting on each 
atom as a function of the atom position can be calculated. By knowing the 3-
dimensional coordinates of the system, applying the atomic force field discussed above 
and assigning initial, randomly generated velocities to each atom, these conditions are 
generally fulfilled. 
 
The propagation of the coordinates and the creation of a time dependent trajectory are 
achieved by integration of the second law of motion over time. Time integration 
algorithms are based on finite difference methods, where time is discretized in short 
time steps, tΔ . If the positions, velocities and forces are known at time t, the 
integration scheme then gives the same quantities at time t t+ Δ . These methods are 
completely deterministic, meaning that once the positions and velocities of each atom 
are known; the state of the system can be predicted at any time in the future or the past. 
Mainly two types off errors are associated with these types of methods: Truncation 
errors, related to the accuracy of the finite difference method with respect to the true 
solution and Round-off errors, related to the finite number of digits used in computer 
arithmetics. Both errors can be reduced by decreasing the size of tΔ . 
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One of the most basic and widely used methods for integration is the Verlet algorithm. 
The basic idea is to write two second-order Taylor expansions for the positions ( )r t , 
one forward and one backward in time:  
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where r is the position, v is the velocity and a is the acceleration. Adding the two 
expression gives: 
 
 ( ) ( ) ( ) ( ) 22r t t r t r t t a t t+ Δ = − −Δ + Δ  (3) 
 
Since we are integrating Newton's equations, ( )a t  is just the force divided by the mass, 
and the force is in turn a function of the positions ( )r t : 
 
  
 ( ) ( )( )F r ta t
m
= −  (4) 
 
It evident from the above equations that the truncation error of the algorithm is of the 
order 4tΔ , since this is the largest term not accounted for in the Taylor expansion. The 
Verlet algorithm is at the same time simple to implement, accurate and has been proven 
to be stable, explaining its large popularity among molecular dynamics simulators. 
However, a problem with the Verlet algorithm is that velocities are not directly 
generated. While they are not needed for the time evolution, they are necessary on 
some occasions. For example, they are required to compute the kinetic energy K, which 
evaluation is necessary to test the conservation of the total energy E=K+V. This is one 
of the most important tests to verify that an MD simulation is proceeding correctly. In 
the Verlet algorithm, the velocities can be computed from the positions by using: 
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But the error associated with this expression is of the order 2tΔ  rather than 4tΔ . 
 
To overcome this deficiency, variants of the Verlet algorithm have been developed. 
One of them is the leapfrog algorithm. To obtain more accurate velocities, the leapfrog 
algorithm calculates velocities at half time steps: 
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After this equation has been evaluated, the velocities of the current time step can be 
calculated using: 
 
 ( ) 2 2
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This equation is necessary when the kinetic energy is needed at time t, for example 
when evaluating the conservation of energy. The atomic positions are then obtained 
from: 
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The leapfrog scheme, which involves only addition of terms compared to the 
subtraction of terms in the Verlet algorithm, results in greater numerical stability and it 
is the algorithm that has been used throughout the work of this thesis. 
 
3.1.3 Running a Molecular Dynamics Simulation 
When setting up a molecular dynamics simulation there are some necessary decisions 
regarding simulations conditions to be made apart from choice of biological system and 
software package. Here I will briefly describe what they are and how I have performed 
the simulations presented in this thesis. 
 
3.1.3.1 Solvation 
Most biological macromolecules exist in a water environment and to properly 
reproduce the behavior of in vivo conditions, the biological molecule must be solvated. 
The representation of solvent can be either explicit or implicit. The explicit model, 
where each water molecule is represented and simulated explicitly, is the most rigorous 
and commonly used method. This representation is required if the important 
interactions between nucleic- or amino acids and water are to be studied. A problem 
with explicit representation of water is that after a proper solvation (about 10 Å of 
water around all sides of the solute), around 90 % of the system consists of water 
atoms, imposing large computational costs compared to the solute molecule alone. 
Several different water models of different complexities exist, but the simple TIP3P[75] 
and SPC/E[56] models has proven to give acceptable results at minimal costs and are 
the most widely used. 
 
To circumvent the considerable increase in computational cost introduced by the 
addition of explicit solvent, implicit representations of water have been developed. In 
these solvation methods the water molecules are replaced with a continuum potential 
that tries to reproduce the solvent effect. This decreases the computational cost 
dramatically but comes at the expense of loss of atomic details of the system. The 
method is mainly used when studying large systems on long time scales. 
 
In this thesis, explicit solvation with the TIP3P water models have been used in all 
papers except in Paper III, where the interaction of TIP3P, SPC/E and TIP5P[76] 
models with Mg2+ ions was compared. 
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3.1.3.2 System Boundary 
In an explicit system, the studied solute molecule and the surrounding water molecules 
make up a finite system with the water molecules at the boundary having solvent on 
one side and vacuum at the other. A common solution to this problem is to duplicate 
the system periodically in all directions to mimic an infinite system. By applying these 
so-called periodic boundary conditions it is ensured that all simulated atoms are 
surrounded by neighboring atoms. Periodic boundary conditions can be used with 
geometries other than the cubic box such as the rhombic dodecahedron and the 
truncated octahedron. This is often done in order to reduce the number of water 
molecules in the system and make it more computationally efficient. Another way of 
solving the boundary problem and at the same time minimize the number of atoms in 
the calculations can be to apply a spherical (i.e. non-periodical) boundary potential. 
This is useful when studying a particular part of a larger system where the region of 
interest is enclosed within a shell. The atoms outside the shell are cut out and deleted 
and the atoms within the shell simulated. The boundary solute atoms in the shell are 
restrained to their starting positions, while waters and ions are prevented from leaving 
by an energy potential shaped as a sphere. 
 
The work presented in Paper II-IV was carried out using periodic boundary conditions 
while the ribosomal A-site, studied in Paper I, was simulated with a spherical boundary 
potential. 
 
3.1.3.3 Ensembles 
Molecular dynamics simulations are usually performed as close to experimental 
conditions as possible and physical properties such as pressure and temperature are 
chosen to achieve this. MD-simulations are performed under different conditions to 
produce a group of microscopic states corresponding to the same macroscopic or 
thermodynamical state, called ensembles. Several ensembles can be used and the most 
widely used in MD-simulations are: 
• Microcanonical ensemble (NVE): The thermodynamic state characterized by a 
fixed number of atoms, N, a fixed volume, V, and a fixed energy, E. This 
corresponds to an isolated system which strives towards maximizing entropy at 
equilibrium. 
• Canonical Ensemble (NVT): The thermodynamic state characterized by a fixed 
number of atoms, fixed volume, and a fixed temperature, T. Will result in a 
minimum of Helmholz free energy at equilibrium. 
• Isobaric-Isothermal Ensemble (NPT): This ensemble is characterized by a fixed 
number of atoms a fixed pressure, P, and a fixed temperature. Will result in a 
minimum of Gibbs free energy at equilibrium. 
In the work presented in this thesis, simulations have been carried out using the NVT 
ensemble in Paper I and the NPT ensemble in Paper II-IV. In order to keep the pressure 
and temperature constant in an NPT ensemble, the Berendsen thermostat and 
barostat[56] can be used. In an canonical ensemble the Nosé-Hoover thermostat[77, 78] 
is often used to control the temperature. 
 
3.1.4 Sampling in Biomolecular Simulations 
The main purpose of a biomolecular simulation is to sample as many configurations of 
the system as possible. Despite a wealth of algorithmic innovations over the past 
decades, MD largely remains the most popular tool for achieving maximum sampling 
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of biomolecular simulations systems. This comes from the simple fact that no other 
method can routinely and reliably outperform MD in sampling efficiency by a 
significant amount.[79] The most straightforward way of obtaining more sampling is of 
course to run longer simulations. But, although explicit-solvent MD simulations are 
now routine performed on the 100 ns – 1 μs scale , modern MD studies still often fall 
short of what is needed for statistically valid equilibrium simulation. Ideally, one would 
like to run a simulation at least 10 times longer than the slowest important timescale in 
a system. Unfortunately, many biomolecular timescales exceed 1 ms, far away from the 
achievable lengths. 
 
Here I will briefly go through the reasons why many configurations are so hard to 
sample adequately and how the sampling can be assessed quantitatively. Methods for 
improving sampling will not be discussed in detail since they have not been extensively 
employed in this thesis. The discussion will be made from the perspective of all-atom, 
explicit solvent MD-simulations. 
 
3.1.4.1 The Sampling Problem 
The configurations of a biomolecular system can be described as an energy landscape 
and the probability of finding the system at a specific configuration x can be expressed 
as: 
  
 ( ) ( )/ bE x k Tx eρ −∝  (9) 
 
where ρ is the probability density function, E is the free energy function (depending on 
the ensemble), kB is Boltzmann's constant, and T is the temperature. An ideal, 
uncorrelated sampling of the generated configurations would follow the distribution in 
equation (9). In an ensemble of N configurations any region of configurational space 
with probability 1/ Nρ >  are likely to be represented and this would be true regardless 
of kinetic barriers among states. In a real life simulations however, the energy 
landscape is riddled with local minima and kinetic barriers preventing an ideal 
sampling (Figure 8). This results in that the sampling is correlated with previous 
configurations and with the initial condition. In a typical simulation of a folded 
biomolecule the problem of reaching the free energy minima of the system is usually 
not limited by the position of the initial structure. The bottleneck of obtaining a 
complete sampling of all relevant configurations will instead be to pass over the 
multiple barriers connecting the substates representing the folded structure. 
 
These transitions over barriers allowing the communication between substates are not 
only essential for the assessment of relative population (thermodynamical stability) of 
substates, the average time spent in each minima also tells gives us the rate constant of 
the actual transitions. The error sizes in determining these properties are directly 
proportional to the number of transitions, making extensive sampling one of the most 
important factors for a successful MD-simulation. 
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Figure 8. Schematic representation of the energy landscape of a biomolecular system. In a 
simulation, the system easily gets trapped in a minima and the crossing of the barriers is crucial for 
successful simulations. 
 
3.1.4.2 Quantitative Assessment of Sampling 
Despite the central role of sampling in simulations and awareness of our limitations in 
obtaining sufficient amounts of it, quantitative assessment of sampling has often 
received relatively little attention. No widely accepted and used methods for 
quantifying the effectiveness of sampling procedures have surfaced during the last 
decades.  
 
The methods for assessing sampling that have been proposed can be divided into two 
groups, absolute and relative measures. Absolute measures attempt to give a binary 
indication of whether convergence has been achieved, while relative measures estimate 
how much sampling has been achieved, e.g. by counting the number of times an event 
occurs. The main limitation of absolute measures lie in the problem of defining an 
unambiguous point where sampling can be considered absolutely converged. In spite of 
this shortcoming, absolute methods, like ergodic measures[80] and cluster counting[81] 
can be valuable in detecting extremely poor sampling or when comparing sampling of 
the same system, obtained with different approaches. In relative measures it is assumed 
that there is a fundamental correlation time for the overall sampling of the system, *corrt . 
The number of effectively independent configurations (the number of uncorrelated 
times a configuration is generated) can then be defined as: 
 
  
 *
eff sim
corr
tN
t
=  (10) 
 
   25 
where simt  is the total simulation time used. In broad terms absolute lack of sampling 
correspond to 1effN <  and to make statistically relevant observations it is desirable that 
10effN > .[79] The problem with this methodology lies of course in determining *corrt  
but several approximations have been proposed. Lyman & Zuckerman[82] derived 
their correlation time from the overall distribution in configuration space, estimating 
the time that must elapse between trajectory frames so that they behave as if 
statistically independent. Another method for determining the overall correlation time, 
using principal component analysis, has been proposed by Hess.[83] These approaches 
have the twin advantages of being based on the full configuration-space distribution (as 
opposed to isolated observables) and of being blindly and objectively applicable to any 
dynamical trajectory. 
 
In Paper IV, cluster counting was used to compare the sampling obtained with one long 
or several shorter simulations of Glutaredoxin 1. 
 
3.1.4.3 Improving Sampling 
Many methods to improve the sampling of standard MD-simulations have been 
suggested over the years. Most of them algorithmic tools, involving e.g. increased 
temperature, but lately also hardware approaches, like running on GPUs and custom 
built hardware have been used to improve the sampling of biomolecular systems. In 
this thesis only the SHAKE algorithm, which reduces the degrees of freedom by 
constraining the high frequency vibrations of hydrogens, and umbrella sampling (see 
Free Energy Calculations section below) have been used. More exhaustive descriptions 
of methods for improving sampling can be found in reviews by Zuckerman[79] and van 
Gunsteren.[84] 
 
3.1.5 Free Energy Calculations 
Perhaps the most important quantity in thermodynamics is Gibbs free energy and it is 
defined as: 
 
 ( ),G T p U pV TS= + +  (11) 
 
where U is the internal energy, pV is volume work, T is the temperature and S is the 
entropy. The free energy of a system is hard to obtain due to the limited sampling of all 
regions of phase space inherent to an MD-simulation. However ways to obtain the free 
energy difference of an event in a molecular system, such as a conformational change, 
binding of a ligand, mutation of a residue or solvation of an atom have been developed. 
The free energy difference of a process provides a thorough description of its driving 
forces and is often reported in biology in investigations of relative stability such as 
comparisons of binding affinities and structural conformations.  
 
The free energy difference between the initial and final state, A BG →Δ , gives us the 
equilibration constant: 
  
 ln A BGK
RT
→Δ= −  (12) 
 
Using transition state theory, the free energy barrier between the two states, †GΔ , gives 
us the rate at which a process occurs: 
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† /G RTk Ae−Δ=  (13) 
 
where R is the molar gas constant and A is a pre-exponential factor with unit 1s− .  
 
Biological macromolecules with large number of atoms have complex free energy 
landscapes which are practically impossible to sample with conventional simulations. 
Several methods to circumvent this problem are used. Two of the most commonly used 
methods are free energy perturbation (FEP) and potential of mean force (PMF) with 
umbrella sampling, each suitable for specific problems. FEP is used for chemical 
process such as mutations of atoms and phase transitions, while PMF is used for 
physical process such as conformational changes. All of the papers except Paper IV 
included in this thesis involve free energy calculations in one or several ways. 
 
3.1.5.1 Free Energy Perturbation 
Free energy perturbation (FEP) is often referred to as an alchemical method since it 
involves transforming atoms in the initial state to the final state in an unphysical way. 
This methodology is possible thanks to the fact that the free energy is a thermodynamic 
state function. This means that its value does not depend on the actual path of the 
process, only on the end states. This allows the use of a thermodynamics cycle, 
exemplified with the difference in GΔ  binding of two small molecules to a 
macromolecule in Figure 9. 
 
 
Figure 9. Thermodynamic cycle. The reactions exemplify the fictive binding of two small molecules (A 
and B) to a large target (R). 
 
The horizontal reactions, which are the experimentally relevant reactions, would be 
computationally very demanding using a physics based potential energy since they 
involve moving the small molecule through the solvent and possibly also requiring 
large conformational changes to allow access to the binding site. Utilizing the fact that 
the free energy is a state function, we can more easily obtain the difference in binding 
affinity between A and B by instead calculating the vertical reactions. The difference in 
affinities is then given by , ,Bind B Bind A RA RB A BG G G G→ →Δ −Δ = Δ −Δ . 
 
To be able to perform the transformation of one residue to another, a hybrid residue 
consisting of both the reactant and product residues is created. The energy of the 
transformation is described by: 
 
 ( ) (1 )B AH H Hλ λ λ= + −  (14) 
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where λ is a coupling parameter ranging from 0 (product state) to 1 (reactant state) in 
small steps. The free energy difference is then calculated by summing the contributions 
from the simulations at all intermediate λ-values: 
 
 
'
1
/
0
ln E RTG RT e
λ λ
−Δ
=
Δ = −∑  (15) 
 
where the angular brackets denote averaging over a simulation performed at a given 
value of λ, E is the energy corresponding to the Hamiltonian in eq. 14 and 
' dE E Eλ λ λ+Δ = − . 
 
In Paper I this methodology has been used to compare the binding affinities of all four 
RNA nucleosides in wobble position of mRNA to the modified uracil cmo5U34 in the 
tRNA anti-codon. In Paper III a variant of FEP, thermodynamic integration, was used 
to compare the free energy of solvation between two Mg2+ parameter sets. 
 
3.1.5.2 Potential of Mean Force and Umbrella Sampling 
A potential of mean force (PMF) is the free energy of a system as a function of some 
internal coordinate or reactions coordinate (x), for example a distance between two 
atoms or the rotation of a dihedral. Unlike the non-physical pathways in the free energy 
perturbation calculations, the PMF is calculated for a physically achievable process. 
The free energy is related to the probability distribution of states as a function of that 
specific coordinate. The probability of finding a certain state can be described as a 
function of the PMF according to the Boltzmann distribution: 
 
  
 ( ) ( )/ bg x k Tx eρ −∝  (16) 
 
where g(x) is the PMF, kb is the Boltzmann constant and T the temperature. As 
previously discussed, MD-simulations do not sample regions that deviate largely from 
the equilibrium state adequately, leading to poor values for the potential of mean force 
of high energy regions. To sample all configurations along the reaction coordinate at 
reasonable computational times, the potentials of mean force are obtained from a series 
of simulations, each having an extra potential (w) to restrain the coordinate to specific 
points along desired reaction coordinate. This potential, referred to as an umbrella 
potential, often takes the form of a harmonic potential: 
  
 ( ) ( )2i i iw x k x x= −  (17) 
 
where x is the value of the reaction coordinate, xi is the constrained value and ki the 
force constant. The PMF is extracted from the probability distribution in each 
simulation after the bias potential has been removed. A popular method to perform this 
post-processing and receive the final PMF is the Weighted Histogram Analysis 
Method[85, 86]. 
 
In Paper I, PMF was used to assess the free energy difference between two alternate 
binding conformations of a base pair and in Paper II it was used to investigate free 
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energy of unfolding of a riboswitch. In Paper III PMF was used to calculate the kinetics 
of Mg2+-water exchange. 
 
3.2 EXPERIMENTAL TECHNIQUES FOR STUDYING RNA AND 
PROTEINS 
A close inter-dependence exists between molecular dynamics simulations and 
experimental techniques. MD-simulations rely on crystallographic and spectroscopic 
methods for three dimensional starting structures of proteins and nucleic acids. Large 
amounts of accurate structures and dynamical data are also needed for the development 
of force fields. On the other hand, experimentalists rely on computer simulations for 
refinement of structures and the detailed analysis and interpretation of results.  
 
The two most successful techniques of obtaining atom resolution structures of proteins 
and nucleic acids are X-ray crystallography and Nuclear Magnetic Resonance (NMR). 
These two methods have been used to solve the majority of the around 80000 structures 
available in the Protein Data Bank (PDB)[87]. The techniques will be briefly explained 
below together with notes on how they relate to the work presented in this thesis. 
 
3.2.1 X-ray Crystallography 
Perhaps the most important technique for revealing the structure of proteins and nucleic 
acids is X-ray crystallography. In this method, the biological molecule is crystallized 
and struck by a high intensity beam of X-ray radiation. The X-rays will diffract into 
many specific directions after hitting the molecule. From the angles and intensities of 
the diffracted beams, a three-dimensional picture of the density of electrons can be 
derived. This density can then be used to determine the positions of the atoms and the 
type of chemical bonds between them. The limiting step in solving a structure using X-
ray crystallography is often the crystallization of the studied molecule. A large uniform 
crystal is needed to obtain high quality data. The most important parameters to 
determine the quality of a published structure is the resolution (commonly between 2 Å 
and 3.5 Å) and the R-factor which is a measure of how well the refined structure 
predicts the observed data. 
 
Historically, the method has been hugely successful and numerous Nobel prizes have 
been awarded for discoveries directly related to X-ray crystallography. Among them 
are the 1914 Physics prize to M. von Laue for the discovery of X-ray diffractions, the 
1962 medicine prize to F. Crick, J. Watson and M. Wilkins for their contributions 
leading to the discovery of the DNA helix, published in 1953.[2] More recent prizes 
include the 2003 Chemistry prize to R. MacKinnon for his structures of the potassium 
channels and the 2009 chemistry prize to V. Ramakrishnan, T.A. Steitz and A.E. 
Yonath for their structures of the ribosome, some of which have been used as starting 
structures in Paper I of this thesis.[22] In paper II and III the X-ray structure of the add 
A-riboswitch[10] has been used.  
 
3.2.2 Nuclear Magnetic Resonance Spectroscopy 
A second method providing atomic resolution structures utilizes the Nuclear Magnetic 
Resonance (NMR) phenomenon. It occurs when the nuclei of certain atoms are 
subjected to a static magnetic field and then exposed to a second oscillating magnetic 
field. For nuclei to experience this phenomenon it must possess a property called spin 
or magnetic momentum, which comes from an odd number of protons in the nuclei. 
Some of the atoms with this property most commonly found in biomolecules are 1H, 
13C, 15N and 25Mg, making them detectable in an NMR experiment.  
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When these atoms are subjected to the alternating magnetic field they give off signals 
called chemical shifts. The chemical shifts also depend on the shielding effect of 
neighboring atoms. This effect gives rise to unique signals dependent on the 
surrounding atoms which can be used to determine the structural environment. The 
spins are also sensitive to the presence of magnetic moments from other spins and are 
therefore “coupled”. How well the spins are coupled is represented by the so called J-
coupling and together with the chemical shifts, they can be used to provide high 
resolution structural information. 
 
Another property that can be measured with NMR spectroscopy is spin relaxation. It is 
evoked by replacing the oscillating magnetic field described above with short radio 
frequency pulses perpendicular to the static field. The pulse causes a perturbation of the 
orientation of NMR-active atoms. What is measured is however what time it takes for 
the system to relax to its initial orientation. Three relaxation parameters can be 
measured in an NMR relaxation experiment, NOE, T1 and T2. NOE, or Nuclear 
Overhauser Effect, is a consequence of dipole–dipole coupling of nuclear spins and can 
be used to in the determination and refinement of structures. T1, or the spin-lattice 
relaxation time, can be thought of as a characterization of the return of the spin 
orientations to their equilibrium positions. T2, or the spin-spin relaxation time, describes 
the change in magnetic field and is related to the exchange of spin between nuclei. The 
time dependence of the relaxation rates provides unique information on the local and 
global dynamics of biomolecules, not available from X-ray crystallography. The 
dynamical data from an NMR relaxation experiment is often presented with the so 
called generalized order parameters (S2), which are obtained using the model-free 
approach of Lipari-Szabo[88]. 
 
NMR spectroscopy requires the studied molecule to be in solution and ability to 
successfully solvate the biomolecule is often the limiting factor in which systems that 
can be studied. The high concentration needed to obtain high quality data sets a limit on 
the size of the systems possible to investigate at about 70 kD and also prevents the 
study insoluble systems such as membrane proteins. 
 
In this thesis, the Mg2+ parameters developed in paper III was optimized to fit data on 
the kinetics of Mg2+-H2O exchange obtained with NMR spectroscopy. In paper IV, 
NMR relaxation parameters are calculated from an MD-trajectory and linked to 
corresponding dynamical events, providing valuable information in the analysis of 
experimental NMR data. The 3-D structures of Glutaredoxin 1 and 3 used in Paper IV 
were solved using solution NMR.[89, 90] 
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4 SUMMARY OF MAIN RESULTS 
 
 
“Science increases our power in proportion as it lowers our pride.” 
- Claude Bernard (1813-78), French physiologist. 
 
 
 
 
 
 
 
 
 
 
 
4.1 PAPER I 
Nucleotide modifications and tRNA anticodon - mRNA codon interactions on the 
ribosome 
 
In the first paper we performed MD simulations of the tRNA anticodon and mRNA 
codon in the decoding center of the ribosome to study the effect of the common tRNA 
modifications cmo5U34 and m6A37. Post transcriptional modifications are very 
common in these positions of tRNA and in tRNAVal these two modifications allow all 
four nucleotides to be successfully read at the wobble position in a codon. This 
extraordinary ability makes tRNAVal a very interesting system for studying the 
influence of modifications on the decoding of mRNA during protein synthesis in the 
ribosome. Previous data suggest that entropic effects are mainly responsible for the 
extended reading capabilities. However, detailed mechanisms have remained unknown 
and the aim of this paper was to provide an atomic explanation of how the decoding 
capabilities are expanded by the cmo5U34 and m6A37 modifications. To elucidate the 
details of these mechanisms and quantify their effects, we performed a wide range of 
simulations: Extensive free energy perturbation coupled with umbrella sampling, 
entropy calculations of tRNA (free and bound to the ribosome) and thorough structural 
analysis of the ribosomal decoding center. After analyzing the entropy of the modified 
and unmodified ASL we found that no prestructuring effect on the tRNA anticodon 
stem loop from the two modifications could be observed. We could however identify 
two other mechanisms that the modifications employ that may contribute to the 
expanded decoding capability. 1. Alternate binding conformations: The extended reach 
of the cmo5U34 allows an alternative binding conformation to be formed for the three 
non cognate base pairs at the wobble position. In the case of Ura-Ura and Ura-Cyt base 
pairing, the highly polar carboxyl group of cmo5 bridges over the distance gap forming 
a hydrogen bond. In the case of the Ura-Gua pair a network of contacts is formed. 
These conformations lie lower in free energy than the standard mismatch binding by 
approximately 1-3 kcal/mol (Figure 10). 2. Increased interactions with the ribosome. 
Additional contacts between the ribosomal residues of the decoding center and anti-
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codon enhance the "catalyzing" effect of the ribosome are observed. One of these 
contacts is the bridging, by the carboxyl group of cmo5U34, between ribosomal C1054 
and the first base of the next mRNA codon. 
 
Figure 10. Relative free energy between the standard and outer (insets) conformations obtained by 
PMF calculations. The outer conformation, made possible with the cmo5U34 modification lie lower in 
energy than standard mismatch binding for three base pairs. The reaction coordinate of the umbrella 
sampling is the distance between O4 of cmo5U34 and H1, H42 and H3 for guanine (red), cytosine (black) 
and uracil (blue) respectively. 
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4.2 PAPER II 
Effects of Ion Environment and Ligand on the RNA Kissing Loops in the add 
Adenine Riboswitch 
 
In the second paper we study the effect of ions and ligand binding on the free energy 
and structure during folding of a riboswitch. Like other structured RNA molecules, 
riboswitches are heavily dependent on cations, especially Mg2+, to function properly 
and can in some aspects be a substitution for ligand binding. We performed MD 
simulations of the adenine-sensing add A-riboswitch to study the effect of ion 
environment and ligand presence on the formation of the kissing hairpin loops, a key 
step in the unfolding mechanism of the aptamer domain. We investigated the aptamer 
domain of add A-Riboswitch in complex with its conjugate ligand and in ligand-free 
state, in Mg2+ and Na+ ion solution Only minor structural differences among the 
systems are observed during the simulation time, but the Mg2+ ions are found to 
provide 33 % more stabilization than the monovalent Na+ ions to the RNA system. The 
opening of the hairpins was simulated using umbrella sampling, using the distance 
between two kissing loops as reaction coordinate. A two-step process was observed in 
all the simulated systems. First, a general loss of stacking and hydrogen bond 
interactions was observed. Lastly, two base pairs, G37-C60 and G38-C61, broke, 
pointing to their essential role in the tertiary kissing loops structure. Moreover, when 
increasing the loop-loop distances, the L3 hairpin displayed more flexibility by 
changing its orientation in the structure while the other conserved its coaxial 
arrangement with rest of the structure (Figure 11). The calculation of free energy 
profiles of the hairpin opening, however, revealed large deviations between replica 
simulations, suggesting insufficient sampling. A fourfold increase of the production 
sampling of each window of some of the simulations did not significantly improve the 
situation. A possible remedy will be to considerably extend the computationally 
expensive initial generation of starting structures for the umbrella sampling. 
 
Figure 11. Conformational changes at three stages of the kissing loop unfolding of the add A-riboswitch. 
The L3 loop is observed to larger conformational changes than L2 during the opening. The ligand is shown in 
spheres and L2 and L3 loop residues are represented in sticks and colored according to the legend 
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4.3 PAPER III 
Magnesium ion-water coordination and exchange in biomolecular simulations 
 
The third paper is a methodology paper that aims to improve the representation of 
magnesium ions in simulation of nucleic acids. Mg2+ ions have an important role in the 
structure and folding mechanism of RNA systems. To properly simulate these 
biophysical processes, the applied molecular models should reproduce, among other 
properties, the kinetics of the ions in water solution. In this paper we studied the 
kinetics of the binding of magnesium ions with water molecules and nucleic acids 
systems in detail, using MD simulation. We began by validating the parameters used in 
biomolecular force fields, such as AMBER and CHARMM, for Mg2+ and for the other, 
most biological relevant ions, Na+, K+ and Ca2+ together with three different water 
models (TIP3P, SPC/E and TIP5P). The initial results showed that Mg2+ ions have a 
slower exchange rate than Na+, K+ and Ca2+ in agreement with the experimental trend, 
but the simulated value underestimates the experimentally observed Mg2+-water 
exchange rate with several orders of magnitudes, irrespective of force field and water 
model. To remedy this situation we developed a new set of parameters for Mg2+ to 
reproduce the experimental kinetic data (Figure 12). The new set was also shown to 
give better reproduction of structural data than existing models. These improvements 
were accompanied with only slight changes (6%) in solvation free energy; the property 
previous parameters were optimized to. We then applied the new parameters set to the 
more physical process of Mg2+ binding with a mono-phosphate model system and with 
a purine riboswitch, the add A-riboswitch. In line with the Mg2+-water results, the 
newly developed parameters showed a better description of the structure and kinetic of 
the Mg2+-phosphate binding than all existing parameters. The characterization of the 
ion binding to the riboswitch system showed that the new parameter set does not affect 
the global structure of the ribonucleic acid system or the number of ions involved in 
direct or indirect binding. A slight decrease in the number of water-bridged contacts 
between A-riboswitch and Mg2+ ion was however observed. Combined, the results 
clearly show that the newly developed parameters improve the kinetic and structural 
description of Mg2+ ions and their applicability in nucleic acid simulation. 
 
Figure 12. Potential of mean force between Mg2+ and a water oxygen around Mg2+ using different 
water models (A) and Mg2+ parameters (B). While water models have little effect on the Mg2+ - water 
exchange rate, our new parameters significantly improve the agreement with experimental data. 
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4.4 PAPER IV 
Motions and Entropies in Proteins as Seen in NMR Relaxation and Molecular 
Dynamics Simulations 
 
In another methodology study, paper IV aims to improve the interpretation of 
experimental data on dynamics. We performed MD simulations of the proteins 
glutaredoxin1 in water to relate the data of dynamics and entropy obtained in NMR 
relaxation experiments with data extracted from a MD trajectory. NMR relaxation is 
the most widely used experimental method to obtain data on dynamics of proteins but it 
is limited to relatively short timescales and to motions of backbone amides, or in some 
cases 13C-H vectors. By relating the experimental data to the complete picture given by 
the molecular dynamics trajectory, valuable insights on the interpretation of the 
experiment can be gained. The internal dynamics and their time scales were estimated 
by calculating the generalized order parameters (S2) for different time windows. We 
went on to calculate the quasiharmonic entropy (S) and compare it to the entropy 
calculated from the generalized order parameter of the amide vector, which is available 
from an NMR experiment. The focus was put on characterizing dynamics that are not 
expressed through the motions of the amide group. We finally evaluated the amount of 
sampling obtained with our molecular dynamics simulations and how it is affected by 
the length of individual simulations by clustering of the sampled conformations. The 
results show that two turns act as hinges, allowing the alpha-helix between them to 
undergo large, long time scale motions that can not be detected in the NMR time 
window. We also find that the entropy obtained from the amide vector is unable to 
account for the often heavily correlated motions of adjacent residues in regions of the 
protein with large dynamics (Figure 13A). Finally we show that the sampling in a total 
of 100 ns molecular dynamics simulation can be can be increased by around 50% by 
dividing the trajectory into 10 replicas with different starting velocities (Figure 13B). 
 
Figure 13. Comparison of NMR and quasiharmonic entropy of GRX1 (A) and amount of sampling 
from different simulations (B). (A): Entropy per residue of GRX1. The red curve is the entropy of the 
15N-1H vector estimated by the quasiharmonic model and blue curve is the entropy of the same atoms 
estimated by the NMR model. The bottom values are the ratios of entropy calculated individually per 
residue in relation to the summed entropy of the segment as a whole. Significant entropy is missed with 
the NMR model (B): Number of conformational clusters produced by 100 ns sampling obtained by 
different simulation lengths and parts. Division of the trajectory into smaller parts yields more sampling. 
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4.5 SAMMANFATTNING PÅ SVENSKA 
Processen med vilken information lagrad i DNA i gener omvandlas till funktionella 
RNA-molekuler och proteiner tillhör de mest fundamentalt viktiga processerna i allt 
känt liv. Även om den processen involverar stora makromolekyler samt rörelser som tar 
relativt lång tid att slutföra beror de alla till syvende och sist på interaktioner mellan 
enskilda atomer i nukleinsyror (DNA och RNA) och amino syror (proteiner). Endast ett 
fåtal experimetella metoder finns tillgängliga som kan studera dessa detaljerade 
interaktioner i de stora system som är involverade i biologiska processer. 
Datorsimuleringar av biologiska system är därför ett oumbärligt verktyg för att förstå 
grundläggande biologiska mekanismer. I den här avhandlingen har Molekyl Dynamik 
(MD) simuleringar används för att studera hur den genetiska koden i mRNA avkodas i 
ribosomen för att forma proteiner och hur en riboswitch fungerar när den reglerar 
uttrycket av en gen. Andra halvan av avhandlingen täcker arbeten som syftar till att 
förbättra de metoder som används för att utföra dessa simuleringar. 
 
I Artikel I undersöks effekten av hur modifikationer (extra atomgrupper) på tRNA 
påverkar avkodningen av mRNA i ribosomen. MD simuleringar utfördes på en del av 
ribosomen, med och utan de undersökta modifikationerna för att bl.a. fastställa 
skillnader i fri energi. Resultaten visar att avkodningen påverkas genom två olika 
mekansimer: Den extra räckvidden som modifikationen ger möjliggör en alternativ 
bindning mellan tRNA och mRNA som är mer stabil än bindingen utan modifikation. 
Modifikatinen resulterar även i flera kontakter mellan tRNA och ribosomen, vilket 
förstärker den katalytiska funktionen. 
 
I Artikel II studeras veckningsmekanismen hos en riboswitch i olika jonmiljöer samt 
med och utan bunden ligand. Utöver traditionella MD simuleringar användes också en 
speciell metod för att ”tvinga” RNA molekylen att öppna sig. Resultaten visar inte 
några signifikanta effekter av vare sig jontyp eller närvaron av bunden ligand. Dock 
observerade vi konsekvent en öppningsmekanism där vissa delar av molekylen är 
betydligt mer flexibla än andra. Mer data kan dock behövas för att kunna dra säkra, 
generella slutsatser. 
 
I Artikel III presenteras en ny modell för att simulera de biologiskt mycket viktiga 
magnesiumjonerna. Den nya modellen har optimerats för att reproducera dynamiska 
egenskaper istället för energetiska som tidigare modellar optimerats för. Vi visar att den 
nya modellen inte bara uppvisar bättre dynamiska egenskper utan även strukturella. 
 
I Artikel IV jämförs dynamisk data erhållet med NMR experiment (ett av få sätt att 
mäta molekylrörelser experimentellt) med dynamik observerad i MD simuleringar. 
Denna analys ger viktiga insikter i hur man ska tolka experimentell data samt hur 
förbättrade simuleringmetoder kan utvecklas. Resultaten visa bl.a. att väsentliga delar 
av entropin hos ett protein inte ses genom NMR p.g.a. ett begränsat tidsfönster samt en 
oförmåga av metoden att beskriva korrelerade rörelser. 
 
4.6 CONCLUDING REMARKS AND FUTURE PERSPECTIVES 
The work presented in this thesis covers both the investigations of fundamental 
biological questions and the improvement of computational and experimental 
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techniques. The ability to answer new, previously unattainable, biological questions 
will always be closely linked to the improvement of methodology and method 
development will continue to be important as long as we do not have a full 
understanding of biology. During my work I encountered the ever present problem of 
insufficient sampling and a sometimes less than intuitive usage of software packages. 
But new and exciting biological fields with questions and problems that can be solved 
with the help of computer simulations have also opened up. 
 
In terms of method development, a few key areas of improvement can be identified. 
One origin for problems when running MD simulations is that most applications of 
software packages as black boxes are not reliable. The expertise needed for setting up 
and running anything but the simplest MD simulations is exclusive to a few research 
groups around the world. To remedy this problem, programs in computational biology 
or bioinformatics could offer undergraduate and graduate-level courses like 
bio/molecular modeling, computational chemistry, or modeling tools for 
experimentalists. Combined with improved user interfaces and documentation, the use 
of MD simulations will be made accessible to a wider range of researchers. 
Furthermore, in the development of the most important features of simulation packages 
such as new sampling techniques, better force fields, hybrid methods and 
parallelization of algorithms there is a lot to be gained in consolidation of efforts. 
Newly developed features should by made available to as many researchers as possible 
for testing and application by decreasing barriers between competing software 
packages. A consolidation of simulation software will also lower the barrier of entry for 
new researcher with fewer, more user friendly choices of software. 
 
Specifically, I have during my work missed simple tools for assessing and comparing 
sampling and the performance of force fields, factors that are essential for any 
successful MD simulation. The problem with insufficient sampling became apparent 
during the simulations of the unfolding of the add A-riboswitch and a significant 
extension of the umbrella sampling will be needed to describe the folding energy 
landscape with certainty. 
 
During my work, groundbreaking discoveries have opened up new exciting biological 
fields of study. In 2011 the first high resolution structures of the eukaryotic ribosome 
was solved.[91-93] The structures show a translational machinery that is significantly 
different from the prokaryotic ribosome in several key structural and mechanistic 
aspects. The new data opens up interesting new possibilities for designing novel 
antibiotics targeting the prokaryotic ribosome. Another emerging and promising field 
involving riboswitches and other RNA motifs is synthetic biology. Computational 
methods have proven to be an effective tool in designing functional RNA functional 
components that can be used as building blocks in larger assemblies.[94, 95] Synthetic 
riboswitches have important applications in biosynthesis processes, where they can be 
implemented as noninvasive sensors of metabolite accumulation and controllers for 
optimizing product yield.[96] Another very interesting application of RNA in synthetic 
biology is it’s recently shown function as an molecular “scaffolding” that can be used 
to engineer the spatial organization of cellular molecules.[97] Further developments in 
these fields will require a detailed atomic understanding of the biology, an area where 
MD simulations have much to offer. 
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